Gary E Schiltz

Research Professor, CMIDD - Center for Molecular Innovation and Drug Discovery
Research Professor, Pharmacology

Emailgary-schiltz@northwestern.edu

Source: Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Gary E Schiltz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

6 Active
18 Finished

CardioExcyte 96 System for Pharmacology Research at Northwestern University
Abdulkadir, S. A., Ardehali, H., Arora, R. K., Burridge, P., George Jr, A. L., Kearney, J. A., McNally, E. M., Schiltz, G. E., Silverman, R. B., Watterson, D. M. & Wilsbacher, L. D.
Office of the Director, National Institutes of Health
6/15/20 → 6/14/21
Project: Research project
Schiltz Lab - Development of Novel MNK Inhibitors for Treating Glioblastoma
Schiltz, G. E.
National Institute of Neurological Disorders and Stroke
9/1/19 → 6/30/24
Project: Research project
Development of Novel MNK Inhibitors for Treating Glioblastoma
Clutter, M., Eckerdt, F. D., Horbinski, C. M., James, C. D., Mishra, R. K., Platanias, L. C. & Schiltz, G. E.
National Institute of Neurological Disorders and Stroke
9/1/19 → 6/30/24
Project: Research project
DART2.0: comprehensive cell type-specific behavioral neuropharmacology
Schiltz, G. E.
Duke University, National Institute of Mental Health
9/14/18 → 9/13/21
Project: Research project
Subproject for SP0046885 Luo Core B
Jin, J., Kandela, I., Luo, X., Mathew, J., Schiltz, G. E., Scott, E. A., Vanoye, C. G. & Wertheim, J. A.
National Institute of Diabetes and Digestive and Kidney Diseases
8/1/18 → 7/31/23
Project: Research project

560 Citations
26 Article
4 Review article
1 Chapter

Heterologous expression of the unusual terreazepine biosynthetic gene cluster reveals a promising approach for identifying new chemical scaffolds
Caesar, L. K., Robey, M. T., Swyers, M., Islam, M. N., Ye, R., Vagadia, P. P., Schiltz, G. E., Thomas, P. M., Wu, C. C., Kelleher, N. L., Keller, N. P. & Bok, J. W., 2020, In: mBio. 11, 4, p. 1-13 13 p., e01691-20.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
Zhai, L., Bell, A., Ladomersky, E., Lauing, K. L., Bollu, L., Sosman, J. A., Zhang, B., Wu, J. D., Miller, S. D., Meeks, J. J., Lukas, R. V., Wyatt, E., Doglio, L., Schiltz, G. E., McCusker, R. H. & Wainwright, D. A., Jun 16 2020, In: Frontiers in immunology. 11, 1185.
Research output: Contribution to journal › Review article › peer-review

Open Access
7 Scopus citations
Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer
Martin, M. C., Zeng, G., Yu, J. & Schiltz, G. E., 2020, (Accepted/In press) In: Journal of Medicinal Chemistry.
Research output: Contribution to journal › Review article › peer-review
A novel strategy to block mitotic progression for targeted therapy
Chi, J. J., Li, H., Zhou, Z., Izquierdo-Ferrer, J., Xue, Y., Wavelet, C. M., Schiltz, G. E., Zhang, B., Cristofanilli, M., Lu, X., Bahar, I. & Wan, Y., Nov 2019, In: EBioMedicine. 49, p. 40-54 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Scopus citations
Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands
Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., Jul 3 2019, In: ChemMedChem. 14, 13, p. 1248-1256 9 p.
Research output: Contribution to journal › Article › peer-review